Skip to main content
Equibles

Walleye Capital LLC

Position in BCYC — Bicycle Therapeutics PLC

CIK 1758720 NEW YORK, NY
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$55,120
-$735,425 QoQ
Shares Held
13,000
-88.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 103 holders
Holding Since
Dec 2023
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Derivatives in BCYC

reported options exposure · as of Jun 30, 2026
CallValue
$32,648
CallShares
7,700
PutValue
$848
PutShares
200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. BCYC ranks #107 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 126,005 $33,608,053
2 CYTK
Cytokinetics Inc
 239,728 $20,422,428
3 BMRN
Biomarin Pharmaceutical Inc
 288,233 $16,492,692
4 IDYA
IDEAYA Biosciences, Inc.
 386,183 $14,393,040
5 REGN
Regeneron Pharmaceuticals, Inc.
 22,596 $14,089,509
6 RARE
Ultragenyx Pharmaceutical Inc.
 334,854 $11,180,775
7 TYRA
Tyra Biosciences, Inc.
 347,898 $11,111,862
8 BCAX
Bicara Therapeutics Inc.
 353,226 $10,487,279

All Filings in BCYC

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $32,648 7,700
2026-06-30 $848 200
2026-06-30 $55,120 13,000
2025-12-31 $708 100
2025-12-31 $790,545 111,659
2025-06-30 $10,425 1,500
2025-06-30 $92,435 13,300
2025-06-30 $271 39
2023-12-31 $2,714,278 150,126